We are live on ! Find out more
TSS

Two Sigma Securities Portfolio holdings

AUM $1.16B
1-Year Est. Return 36.23%
This Fund
S&P 500
This Quarter Est. Return
+12.14%
1 Year Est. Return
+36.23%
3 Year Est. Return
+108.69%
5 Year Est. Return
+124.54%
10 Year Est. Return
+352.99%
AUM
$11.2B
AUM Growth
+$2.97B
Cap. Flow
-$201M
Cap. Flow %
-1.8%
Top 10 Hldgs %
63.2%
Holding
2,721
New
634
Increased
459
Reduced
654
Closed
956

Sector Composition

Rank Sector Weight
1 Miscellaneous 98.14%
2 Financials 0.4%
3 Consumer Discretionary 0.25%
4 Technology 0.21%
5 Communication Services 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLNA
1701
Filana Therapeutics
FLNA
$34.9M
$14K ﹤0.01%
+10,558
New +$12.1K
IDSA
1702
DELISTED
Industrial Services of America
IDSA
$14K ﹤0.01%
+11,352
New +$13.8K
SDR
1703
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$14K ﹤0.01%
+13,856
New +$14.2K
DAC icon
1704
Danaos Corp
DAC
$2.96B
$13K ﹤0.01%
+1,032
New +$13.1K
PRSO icon
1705
Peraso
PRSO
$7.28M
$13K ﹤0.01%
94
+44
+88% +$6.33K
PULM icon
1706
Pulmatrix
PULM
$5.22M
$13K ﹤0.01%
+507
New +$17K
RVP icon
1707
Retractable Technologies
RVP
$20.5M
$13K ﹤0.01%
+20,134
New +$14.6K
TOVX icon
1708
Theriva Biologics
TOVX
$10.9M
$13K ﹤0.01%
+75
New +$12.4K
VIVS
1709
VivoSim Labs
VIVS
$3.47M
$13K ﹤0.01%
+54
New +$13.6K
TRIL
1710
DELISTED
Trillium Therapeutics Inc.
TRIL
$13K ﹤0.01%
+18,947
New +$23.2K
SDLP
1711
DELISTED
SEADRILL PARTNERS LLC
SDLP
$13K ﹤0.01%
+1,532
New +$18K
LGCY
1712
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$13K ﹤0.01%
+26,357
New +$35.6K
GCVRZ
1713
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$13K ﹤0.01%
28,656
-1,712
-6% -$799
BDRX
1714
Biodexa Pharmaceuticals
BDRX
$818K
0
BGMS
1715
Bio Green Med Solution Inc
BGMS
$5.82M
0
EDSA icon
1716
Edesa Biotech
EDSA
$39.8M
$12K ﹤0.01%
+265
New +$13.1K
LGMK
1717
DELISTED
LogicMark
LGMK
$12K ﹤0.01%
+3
New +$16K
UAMY icon
1718
United States Antimony
UAMY
$687M
$12K ﹤0.01%
+26,179
New +$14.9K
WKHS icon
1719
Workhorse Group
WKHS
$33M
$12K ﹤0.01%
7
+3
+75% +$7.86K
TMBR
1720
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$12K ﹤0.01%
9
-4
-31% -$6.49K
IDXG
1721
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$12K ﹤0.01%
1,550
+416
+37% +$3.91K
ASNA
1722
DELISTED
Ascena Retail Group, Inc.
ASNA
$12K ﹤0.01%
545
-269
-33% -$12.1K
YRIV
1723
DELISTED
Yangtze River Port and Logistics Limited Common Stock
YRIV
$12K ﹤0.01%
+20,960
New +$30.3K
CTIC
1724
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$12K ﹤0.01%
+12,091
New +$12.7K
OESX icon
1725
Orion Energy Systems
OESX
$110M
$11K ﹤0.01%
+1,239
New +$11.4K

Similar funds

Two Sigma Securities's Q1 2019 Portfolio in Review

As of Q1 2019, Two Sigma Securities held 2,721 positions worth $11.2B, up 36% from $8.19B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Two Sigma Securities's Q1 2019 filing shows 634 new, 459 increased, 654 reduced and 956 closed positions. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 93,798 shares worth $8.61M. The largest sale was State Street Financial Select Sector SPDR ETF, an estimated $24M.

By sector, the portfolio is most concentrated in Miscellaneous at 98% of assets, up from 96% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Two Sigma Securities's largest Q1 2019 buy was State Street Health Care Select Sector SPDR ETF: 93,798 shares worth $8.61M.
  • Two Sigma Securities added most to State Street SPDR S&P 500 ETF Trust in Q1 2019, an estimated $34.6M increase.
  • Two Sigma Securities's biggest Q1 2019 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $24M.
  • Two Sigma Securities fully exited iShares 1-3 Year Treasury Bond ETF in Q1 2019, selling an estimated $9.6M.
  • Two Sigma Securities's ten largest holdings make up 63% of its $11.2B portfolio in Q1 2019.
  • Two Sigma Securities opened 634 new positions and closed 956 in Q1 2019.
  • Two Sigma Securities's portfolio value rose 36% quarter-over-quarter to $11.2B.

Based on Two Sigma Securities's 13F filing for Q1 2019, filed 15 May 2019.